Biotherapeutics News and Research

RSS

Some phages employ new strategy to avoid becoming the next casualty of DNA-dicing enzymes

Bacteria and the viruses that infect them are engaged in a molecular arms race as ancient as life itself. Evolution has equipped bacteria with an arsenal of immune enzymes, including CRISPR-Cas systems, that target and destroy viral DNA. But bacteria-killing viruses, also known as phages, have devised their own tools to help them outmaneuver even the most formidable of these bacterial defenses.

9 Dec 2019

IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, today announced it has entered into a collaboration agreement with Adaptate Biotherapeutics, developers of antibody-based therapeutics for modulation of gamma delta T-cells.

From FairJourney Biologics 4 Dec 2019

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease compared to the investigational treatment ZMapp, according to published results from a clinical trial conducted in the Democratic Republic of the Congo.

2 Dec 2019

Lonza launches new basal and feed medium to optimize protein production

Lonza has further expanded its cell culture media portfolio with the addition of the eCHO Basal Medium and Feed, which has been designed to optimize protein production by delivering a consistent yield and highly viable cells while keeping lactate levels to a minimum for optimal protein integrity.

From Lonza 14 Nov 2019

LG Chem Life Sciences expands collaboration with Avacta

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to provide an update on the Affimer therapeutics development partnership and license agreement with LG Chem Life Sciences, part of the South Korean LG Group, to develop Affimer therapeutics in several disease areas.

From LG Chem Life Sciences Innovation Center, Inc. 14 Nov 2019

BioStreamline project outcomes

CPI have reported successful outcomes the £11.

From Sphere Fluidics 16 Oct 2019

BioStreamline: Streamlining the development of next generation biotherapeutics

A collaboration to streamline the development of cost-effective next generation biotherapeutics will host a dissemination event at CPI.

From Sphere Fluidics 16 Oct 2019

Unique immune cell linked to remission in patients with triple negative breast cancer

A unique type of immune cell has been discovered in human breast tissue, and breast cancer patients with more of these cells are more likely to survive, finds new research from the Francis Crick Institute and King's College London.

From The Francis Crick Institute 9 Oct 2019

Texas Biomed scientists continue testing therapies and vaccines for Ebola virus

In mid-August 2019, human clinical trials were halted in the current Ebola epidemic that has claimed more than 2,100 lives in Africa.

26 Sep 2019

New NC State-led project to focus on the future of biomanufacturing

A new 5-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.

29 Aug 2019

LUCA Biologics develops live biotherapeutics for unmet medical needs in women's health

LUCA Biologics, a biotechnology company co-founded by Dr. Jacques Ravel, announced today it will develop live biotherapeutics for widespread, unmet medical needs in women's health. Ravel will serve as LUCA's Chief Scientist.

6 Aug 2019

New research explains why some cancers don't respond to immunotherapy

New research has uncovered a mechanism thought to explain why some cancers don't respond to a widely used form of immunotherapy called "checkpoint inhibitors" or anti-PD-1.

6 Aug 2019

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

IONTAS Limited, a leader in antibody discovery and optimization of human monoclonal antibody libraries, today announced an agreement with Teva Pharmaceuticals (Teva) to apply its technologies and know-how to the optimization of human antibodies for use as biotherapeutics.

From FairJourney Biologics 31 Jul 2019

Novel therapeutic strategy for treating Lafora Disease shows promise in preclinical study

A team of scientists have designed and tested in mice a novel and promising therapeutic strategy for treating Lafora Disease, a fatal form of childhood epilepsy.

25 Jul 2019

Researchers completely eliminate all traces of HIV from infected mice

For the first time, researchers have successfully removed HIV-1 DNA from the genomes of living animals, a critical step towards a potential cure for the disease.

4 Jul 2019

Using Light Scattering to Characterize Protein-Nucleic Acid Interactions

Harnessing the interactions between DNA, RNA, and proteins holds much promise for detecting biomarkers, diagnosing disease, and improving cancer-targeting therapeutics. Quantifying these interactions is essential for understanding and controlling their biomolecular mechanisms.

From Waters | Wyatt Technology 26 Jun 2019

Biotherapeutics News and Research

Some phages employ new strategy to avoid becoming the next casualty of DNA-dicing enzymes

IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

Lonza launches new basal and feed medium to optimize protein production

LG Chem Life Sciences expands collaboration with Avacta

BioStreamline project outcomes

BioStreamline: Streamlining the development of next generation biotherapeutics

Unique immune cell linked to remission in patients with triple negative breast cancer

Texas Biomed scientists continue testing therapies and vaccines for Ebola virus

New NC State-led project to focus on the future of biomanufacturing

LUCA Biologics develops live biotherapeutics for unmet medical needs in women's health

New research explains why some cancers don't respond to immunotherapy

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

Novel therapeutic strategy for treating Lafora Disease shows promise in preclinical study

Researchers completely eliminate all traces of HIV from infected mice

Using Light Scattering to Characterize Protein-Nucleic Acid Interactions

Stability Testing of Therapeutic Proteins using DLS and Machine Learning

CityU scientist receives grant for new way to cultivate 10 distinct probiotic bacteria

Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

Sartorius Stedim Biotech launches new SIMCA 16 software for multivariate data analytics

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News